189 related articles for article (PubMed ID: 24220856)
21. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
22. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
Lin H; Shen L; Lin Q; Dong C; Maswela B; Illahi GS; Wu X
Biomed Pharmacother; 2020 Mar; 123():109711. PubMed ID: 31884343
[TBL] [Abstract][Full Text] [Related]
23. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
24. Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.
Shuang T; Wang M; Shi C; Zhou Y; Wang D
FEBS Lett; 2015 Oct; 589(20 Pt B):3154-64. PubMed ID: 26363097
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells.
Park GB; Kim D
Neoplasia; 2019 Feb; 21(2):206-215. PubMed ID: 30622051
[TBL] [Abstract][Full Text] [Related]
26. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.
Zhu X; Li Y; Xie C; Yin X; Liu Y; Cao Y; Fang Y; Lin X; Xu Y; Xu W; Shen H; Wen J
Int J Cancer; 2014 Sep; 135(6):1286-96. PubMed ID: 24510775
[TBL] [Abstract][Full Text] [Related]
27. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
Zhou J; Gong G; Tan H; Dai F; Zhu X; Chen Y; Wang J; Liu Y; Chen P; Wu X; Wen J
Oncol Rep; 2015 Jun; 33(6):2915-23. PubMed ID: 25962395
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
[TBL] [Abstract][Full Text] [Related]
30. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells.
Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P
PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
Uhr K; Prager-van der Smissen WJC; Heine AAJ; Ozturk B; van Jaarsveld MTM; Boersma AWM; Jager A; Wiemer EAC; Smid M; Foekens JA; Martens JWM
PLoS One; 2019; 14(5):e0216400. PubMed ID: 31063487
[TBL] [Abstract][Full Text] [Related]
32. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
Xu CZ; Xie J; Jin B; Chen XW; Sun ZF; Wang BX; Dong P
Int J Clin Exp Pathol; 2013; 6(7):1351-61. PubMed ID: 23826416
[TBL] [Abstract][Full Text] [Related]
33. Evidence for miR-17-92 and miR-134 gene cluster regulation of ovarian cancer drug resistance.
Zhu H; Yang SY; Wang J; Wang L; Han SY
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2526-31. PubMed ID: 27383301
[TBL] [Abstract][Full Text] [Related]
34. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ
Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165
[TBL] [Abstract][Full Text] [Related]
36. Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel.
Jin B; Liu Y; Wang H
Cell Biochem Biophys; 2015 May; 72(1):275-82. PubMed ID: 27040946
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples.
Li X; Lu Y; Chen Y; Lu W; Xie X
BMC Cancer; 2013 Apr; 13():216. PubMed ID: 23627607
[TBL] [Abstract][Full Text] [Related]
38. A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.
Han X; Zhen S; Ye Z; Lu J; Wang L; Li P; Li J; Zheng X; Li H; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2017; 41(3):973-986. PubMed ID: 28222434
[TBL] [Abstract][Full Text] [Related]
39. MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7.
Jia Z; Wang K; Wang G; Zhang A; Pu P
PLoS One; 2013; 8(1):e55008. PubMed ID: 23383034
[TBL] [Abstract][Full Text] [Related]
40. MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.
Li Y; Zhang J; Liu Y; Zhang B; Zhong F; Wang S; Fang Z
BMC Cancer; 2018 Apr; 18(1):404. PubMed ID: 29642855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
